scispace - formally typeset
H

Heiner Mönig

Researcher at University of Kiel

Publications -  46
Citations -  876

Heiner Mönig is an academic researcher from University of Kiel. The author has contributed to research in topics: Cirrhosis & Pancreatitis. The author has an hindex of 17, co-authored 46 publications receiving 833 citations.

Papers
More filters
Journal ArticleDOI

Longitudinal imaging reveals pituitary enlargement preceding hypoplasia in two brothers with combined pituitary hormone deficiency attributable to PROP1 mutation.

TL;DR: It is suggested that early pituitary enlargement may be the typical course in patients with PROP-1 mutations in whom pituitaries are not indicated, and altered expression of early transcription factors could be involved.
Journal ArticleDOI

Expression of leptin and leptin receptor during the development of liver fibrosis and cirrhosis.

TL;DR: Leptin is expressed at increasing levels in activated hepatic stellate cells in vivo, which may be a source of increased leptin tissue and serum levels contributing to the pathophysiology and morphological changes of chronic liver disease.
Journal ArticleDOI

Can peripheral blood γδ T cells predict osteonecrosis of the jaw? An immunological perspective on the adverse drug effects of aminobisphosphonate therapy

TL;DR: It is proposed Vγ9Vδ2 T cells show a strong potential to serve as harbingers of possible adverse immune effects of n‐BP therapy, particularly in those patients already having a compromised immune system as they may be most vulnerable to the development of conditions such as BAONJ.
Journal ArticleDOI

Selective inhibition of drug oxidation after simultaneous administration of two probe drugs, antipyrine and tolbutamide.

TL;DR: The two main inferences are that tolbutamide and antipyrine are metabolished by different forms of cytochrome P-450, and that a battery of model substrates is needed to investigate the inhibitory effects of a drug in man.